Pharmacoepidemiology and Drug Safety
-
Publication Venue For
-
Continuity of Prescribing and Medication Adherence in Patients with Schizophrenia and Cardiometabolic Comorbidities.
25:207-207.
2016
-
Erratum to "Pediatric post-marketing safety systems in North America: Assessment of the current status." [Pharmacoepidemiology and Drug Safety, 24, (2015), 785-792] Doi: 10.1002/pds.3813.
25:110-111.
2016
-
Comparing Patient-centered Outcomes after Uterus-conserving Procedures for Uterine Fibroids Using a Linked Electronic Medical Record (EMR)-claims Database.
24:357-357.
2015
-
Immunization Status at Discharge from the Neonatal Intensive Care Unit (NICU).
24:13-13.
2015
-
Long-Term Outcomes of Vaginal Mesh vs. Native Tissue Repair for Anterior Vaginal Wall Prolapse.
22:12-13.
2013
-
Pediatric Pharmacoepidemiology Safety Study with Long-Term Use of Sertraline: The SPRITES Study.
22:333-334.
2013
-
Relative Performance of Approaches Handling Immortal Person-Time in Comparative Effectiveness Research: A Simulation Study.
22:3-3.
2013
-
Use of Glyburide vs. Insulin for Treatment of Gestational Diabetes in the US, 2000-2010.
22:145-145.
2013
-
Angioedema Events and Use of Drugs That Act on the Renin-Angiotensin-Aldosterone System (RAAS).
21:162-163.
2012
-
Characteristics Associated with Delays in Diagnosis of Pompe Disease among Patients Enrolled in the Pompe Registry.
21:456-457.
2012
-
Communicating Quantitative Benefit and Risk Summaries in Promotional Labeling or Print Advertising: A Literature Review.
21:220-220.
2012
-
Confounding Adjustment in a Distributed Data System without Sharing of Individual-Level Data.
21:259-260.
2012
-
Comparative Cardiovascular (CV) Safety of Dementia Drugs among Medicare Beneficiaries.
20:S122-S123.
2011
-
Selecting an Appropriate Comparison Group: Characterizing Treated and Untreated Patients in the Pompe Registry.
20:S176-S176.
2011
-
Use and Outcomes of Partial Knee Replacement (PKR) vs Total Knee Replacement (TKR) among Medicare Beneficiaries, 2000-2009.
20:S137-S137.
2011
-
Evaluating quantitative benefit-risk analysis for drug-approval decision making in Europe and the United States.
17:S26-S26.
2008
-
Population-based drug-related anaphylaxis in children and adolescents captured by South Carolina Emergency Room Hospital Discharge Database (SCERHDD) (2000-2002)..
16:1255-1267.
2007
-
Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis.
16:S183-S183.
2007
-
Benefit assessment of therapeutic products: the Centers for Education and Research on Therapeutics..
16:5-16.
2007
-
Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users..
15:710-718.
2006
-
Patients willingness to accept risk-benefit trade-offs in treating Crohn's disease.
15:S138-S139.
2006
-
Willingness to accept risk-benefit tradeoffs: Pharmacoepidemiology meets preference measurement.
15:S36-S37.
2006
-
Frequency of high-risk use of QT-prolonging medications..
15:361-368.
2006
-
Comparing data mining methods on the VAERS database..
14:601-609.
2005
-
Managing the risks of therapeutic products: proceedings of a workshop..
14:619-628.
2005
-
Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study..
14:407-415.
2005
-
Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly..
13:781-787.
2004
-
Racial/ethnic variations in non-steroidal anti-inflammatory drug (NSAID) use among patients with osteoarthritis..
13:683-694.
2004
-
Benefit the patient, manage the risk: a system goal..
13:269-276.
2004
-
Improving communication of drug risks to prevent patient injury: proceedings of a workshop..
12:183-194.
2003
-
The need for a national infrastructure to improve the rational use of therapeutics..
11:319-327.
2002
-
Automated support for pharmacovigilance: a proposed system..
11:121-125.
2002
-
Characterizing imbalance in the tails of the propensity score distribution
2021
-
Controlling for differential regression to the mean using summary measures of pre-treatment laboratory values in propensity scores
2021
-
Do Medicare part D low-income subsidies narrow disparities in orally-administered antimyeloma therapy initiation?
2021
-
Efficacy and safety of treatments for nonmetastatic castration-resistant prostate cancer: A matching-adjusted indirect comparison and network meta-analysis
2021
-
Impact of race, ethnicity, and sex on treatment of non-valvular atrial fibrillation
2021
-
Prevalence of osteoporosis and its treatment among women >= 50 in NHANES: 1999-2018
2021
-
Use of negative control outcomes to detect mismeasured confounders in administrative data
2021
-
Using negative control outcomes to assess the comparability of treatment groups among postmenopausal women switching osteoporosis therapy
2021
-
Visualization methods to examine treatment patterns in pharmacoepidemiology: An example using osteoporosis medications
2021
-
Comparative effectiveness and safety of systemic treatments for metastatic castration-sensitive prostate cancer: A parametric survival network meta-analysis of randomized controlled trials
2020
-
Comparing cardiovascular benefits of sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in older adults with diabetes
2020
-
Comparing inverse probability of treatment and standardized mortality ratio weights in a small sample setting
2020
-
Estimating vaccine effects: A comparison of causal methods
2020
-
History of lipid lowering therapy use among adults initiating treatment with proprotein convertase subtilisin/kexin type 9 antibody inhibitors in the United States, 2015-2019
2020
-
Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation
2020
-
Newer second-line glucose-lowering drugs versus thiazolidinediones and cirrhosis risk in type 2 diabetes
2020
-
Real world treatment patterns following the initiation of proprotein convertase subtilisin/kexin type 9 antibody inhibitors among adults in the United States, 2015-2019
2020
-
The role of high-deductible health plans on the use of lenalidomide
2020
-
Visual space: Using visualization in pharmacoepidemiology to design and disseminate valid real-world evidence in a structured framework
2020
-
Who are we missing?: Underrepresentation of data sources used for pharmacoepidemiology research in the United States
2020
-
Dose-dependent effects of gabapentin and pregabalin on the day of surgery in total hip and knee arthroplasties
2019
-
Heatwaves and heat-sensitizing medications in vulnerable older adults
2019
-
Performance of machine learning algorithms for hysterectomy risk prediction among women with endometriosis in the United States
2019
-
Using Negative Control Outcomes to Assess the Comparability of Osteoporosis Treatment Groups
2019
-
Administrative claims data to support pragmatic clinical trial outcome ascertainment using PCORnet adaptable trial as an example
2018
-
Agreement between electronic health records and administrative claims data for patients with multiple myeloma
2018
-
Assessment of transfusion-related acute lung injury (TRALI) after blood transfusion
2018
-
Chronic myeloid leukemia among veterans from 2006 to 2015: Trends in utilization of tyrosine kinase inhibitors
2018
-
Do people understand benefits and risks? Even ineffective treatments for delaying Alzheimer's disease are preferable to "doing nothing" for many older adults
2018
-
Electronic health records (EHR) vs Medicare claims data: Comparing the relative completeness of non-fatal outcomes in a linked cohort
2018
-
Estimating cumulative risk in the presence of competing events and dependent censoring in pharmacoepidemiology studies
2018
-
Linking electronic health data in pharmacoepidemiology: Guidance for assessing appropriateness and feasibility
2018
-
Long live the "medical data janitors": International data quality assurance practices in distributed data networks
2018
-
Predictors of outpatient cardiac rehabilitation referral among hospitalized heart failure patients: The Atherosclerosis Risk in Communities (ARIC) study
2018
-
Too many cooks in the kitchen: The association of medication adherence and diabetes control with number and type of prescribing physicians
2018
-
Validation of transfusion administrations among potential transfusion-related acute lung injury (TRALI) patients included in the sentinel distributed database
2018
-
Assessment of Transfusion-Related Acute Lung Injury after Red Blood Cell, Plasma and Platelet Administration: Initial Results in the Sentinel System
2017
-
Development and Validation of Patient-Reported Risk, Efficacy and Benefit Measures in the Context of DTC Prescription Drug Advertising
2017
-
Examining Parental Adherence as a Predictor of Child SSRI Adherence in Pediatric Anxiety
2017
-
Expansion of the US FDA Sentinel System to Inpatient Blood Transfusion Data from Hospital Corporation of America: New Surveillance Options
2017
-
Heat-Related Outcomes and Medication Use in Older Adults with Heart Failure
2017
-
Trends in Pediatric Acetaminophen Exposures Reported to the National Poison Data System in the United States
2017
-
Utilization of Attention Deficit Hyperactivity Disorder Medications (ADHD) by Adults in 13 Countries
2017
-
Childhood Obesity in Relation to Poor Asthma Control and Exacerbations
2016
-
Everyone Isn't Average: Quantifying Heterogeneity in Crohn's Disease Patients' Benefit-Risk Tradeoff Preferences
2016
-
Global Utilization of Attention Deficit Hyperactivity Disorder Medications - Preliminary Results
2016
-
Risk Factors for Major Bleeding Events in Rivaroxaban Users with Atrial Fibrillation: A Nested Case-Control Study
2016
-
Initial Prescription Medication for Children with Anxiety: Concordance with Evidence
2015
-
Outcomes of Facility-level Use of Ferumoxytol versus Other Intravenous Iron Formulations in Incident Hemodialysis Patients
2015
-
Rates of Opioid-Managed Pelvic Pain after Sterilization by Implanted Device vs. Tubal Ligation, US 2005-2011
2014
-
New Approaches to Account for Selection Bias and Confounding by Frail Health Status
2013
-
Obesity and Metabolic Abnormalities in Antipsychotic Exposed Youth
2013
-
Standard Errors & Confidence Limits for Doubly Robust Estimation
2011
-
Patients' Value of Benefits and Harms of Migraine Treatments
2010